Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
- $200,000
- 3
- May 19, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Or read the full text and all 3 standing review criteria here, free with an account. Create free account
Summary
The secondary use of archived data and/or biospecimen collections represents a critical opportunity to advance research in maternal, pediatric, and adolescent HIV. These resources enable investigators to validate prior findings, address novel hypotheses, and generate insights that extend beyond the scope of the original studies…
Related NIH announcements
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
$200k
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
$200k
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
The full announcement, free with an account
- The full announcement text, not just the first two sentences
- All 3 standing review criteria National Institutes of Health applies to this kind of proposal (its standard framework, not criteria written for this announcement)
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
- A Reviewer Scorecard of your draft against these criteria
More from National Institutes of Health
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
$500k
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Related by subject
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
$150k
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
$300k
Capacity Building Grants for Non-Land-Grant Colleges of Agriculture Program
$750k
Hiring in this research area now
- Technology-Driven Integrative Physiology AI-Enabled Cell, Molecular and Genomic Biol Asst/Assoc ProfSalary is commensurate with education and experience.
- Postdoctoral Position (f/m/d) in Computational Viral Genomics and EvolutionE 13 TV EntGO Bund
- Postdoctoral Research Assistant in Statistical Machine Learning for Genomics£39,424 to £47,779 per annum (with potential extension to £53,483), inclusive of £1,730 Oxford University Weighting